The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Research works printed but not linked: 27
- Abbate, 2008, Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction, Circulation, 117, 2670, 10.1161/CIRCULATIONAHA.107.740233 · DOI · Paper page
- Arola, 2000, Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis, Cancer Res., 60, 1789
- Berthiaume, 2007, Adriamycin-induced oxidative mitochondrial cardiotoxicity, Cell Biol. Toxicol., 23, 15, 10.1007/s10565-006-0140-y · DOI · Paper page
- Bertinchant, 2003, Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings, Clin. Chim. Acta, 329, 39, 10.1016/S0009-8981(03)00013-5 · doi:10.1016/s0009-8981(03)00013-5
- Bujak, 2009, The role of IL-1 in the pathogenesis of heart disease, Arch. Immunol. Ther. Exp (Warsz)., 57, 165, 10.1007/s00005-009-0024-y · DOI · Paper page
- Chen, 2006, Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice, Free Rad. Biol. Med., 41, 1470, 10.1016/j.freeradbiomed.2006.08.006 · DOI
- Childs, 2002, Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2: Bax ratio, Cancer Res., 62, 4592
- Del Rio, 2005, A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress, Nutr. Metab. Cardiovasc. Dis., 15, 316, 10.1016/j.numecd.2005.05.003 · DOI · Paper page
- Dinarello, 1996, Biologic basis for interleukin-1 in disease, Blood, 87, 2095, 10.1182/blood.V87.6.2095.bloodjournal8762095 · DOI · Paper page
- Gabellec, 1997, Analysis of brain mRNA by reverse transcription-polymerase chain reaction and hybridization with digoxigenin-labeled DNA probe, Brain Res., 2, 145
- Horan, 2006, Anthracycline cardiotoxicity, Eur. Heart J., 27, 1137, 10.1093/eurheartj/ehi702 · doi:10.1093/eurheartj/ehi702
- Hori, 2009, Oxidative stress and left ventricular remodelling after myocardial infarction, Cardiovasc. Res., 81, 457, 10.1093/cvr/cvn335 · DOI · Paper page
- Ikonomidis, 2008, Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis, Circulation, 117, 2662, 10.1161/CIRCULATIONAHA.107.731877 · DOI · Paper page
- Ing, 1999, Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, bak, and bcl-x, Circ. Res., 84, 21, 10.1161/01.RES.84.1.21 · DOI · Paper page
- Kalyanaraman, 2002, Doxorubicin-induced apoptosis: implications in cardiotoxicity, Mol. Cell. Biochem., 234–235, 119, 10.1023/A:1015976430790 · DOI · Paper page
- Kusuoka, 1991, Alterations of intracellular calcium homeostasis and myocardial energetics in acute adriamycin-induced heart-failure, J. Cardiovasc. Pharmacol., 18, 437, 10.1097/00005344-199109000-00017 · DOI
- Lim, 2002, Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsachieviral myocarditis, Circulation, 105, 1278, 10.1161/circ.105.11.1278 · DOI
- Mann, 2002, Inflammatory mediators and the failing heart: past, present, and the foreseeable future, Circ. Res., 91, 988, 10.1161/01.RES.0000043825.01705.1B · DOI · Paper page
- Minotti, 1999, Role of iron in anthracycline cardiotoxicity: new tunes for an old song?, FASEB J., 13, 199, 10.1096/fasebj.13.2.199 · DOI · Paper page
- O'Brien, 2006, Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals, Lab. Anim., 40, 153, 10.1258/002367706776319042 · DOI · Paper page
- Singal, 1998, Doxorubicin-induced cardiomyopathy, N. Engl. J. Med., 339, 900, 10.1056/NEJM199809243391307 · DOI · Paper page
- Steinherz, 1991, Cardiac toxicity 4 to 20years after completing anthracycline therapy, JAMA, 266, 672, 10.1001/jama.266.12.1672 · doi:10.1001/jama.266.12.1672
- Suzuki, 2001, Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia–reperfusion injury associated with reduction of apoptosis, Circulation, 104, 308, 10.1161/hc37t1.094871 · DOI · Paper page
- Temma, 1997, Ca2+ overloading causes the negative inotropic effect of doxorubicin in myocytes isolated from guinea-pig hearts, Eur. J. Pharmacol., 19, 235, 10.1016/S0014-2999(96)00994-6 · doi:10.1016/s0014-2999(96)00994-6
- Torti, 1986, Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy, Cancer Res., 46, 3722
- Young, 1981, The anthracycline antineoplastic drugs, N. Engl. J. Med., 305, 139, 10.1056/NEJM198107163050305 · DOI · Paper page
- Zhang, 2008, Interleukin-1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse, Biomed. Pharmacother., 63, 501, 10.1016/j.biopha.2008.09.014 · DOI
Cited by
Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform
Skardal, A., Murphy, S. V., Devarasetty, M., Mead, I., Kang, H.-W., Seol, Y.-J., Shrike Zhang, Y., Shin, S.-R., Zhao, L., Aleman, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08879-x · Cited by 623
Inflammasomes in carcinogenesis and anticancer immune responses
Zitvogel, L., Kepp, O., Galluzzi, L., & Kroemer, G. (2012) · Nature Immunology · doi:10.1038/ni.2224 · Cited by 593
Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
Renu, K., V.G., A., P.B., T. P., & Arunachalam, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.043 · Cited by 588
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Hanna, A., & Frangogiannis, N. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07071-0 · Cited by 418
Quagliariello, V., De Laurentiis, M., Rea, D., Barbieri, A., Monti, M. G., Carbone, A., Paccone, A., Altucci, L., Conte, M., Canale, M. L., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01346-y · Cited by 367
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Vyas, D., Laput, G., & Vyas, A. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s60114 · Cited by 310
Targeting Interleukin-1 in Heart Disease
Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013) · Circulation · doi:10.1161/circulationaha.113.003199 · Cited by 302
Metadata
- Authors
- Zhu, J., Zhang, J., Xiang, D., Zhang, Z., Zhang, L., Wu, M., Zhu, S., Zhang, R., & Han, W.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 643
- Issue
- 2-3
- Pages
- 247-253
- ISSN
- 0014-2999
- Cited by
- 67
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.